HAVNHAVN Life Sciences Inc.
0.0300CAD0.00%Mkt Cap: 322006 $P/E: —25d ago
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap322.01K $
Enterprise Value—
Revenue (TTM)—
Gross Profit65.32K $
Net Income (TTM)-16.34M $
Revenue/Share—
Last Price0.0300 CAD
Fiscal Year End—
MR Quarter—
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA4196213058
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.53
EPS (TTM)—
EPS (Forward)—
52W Range
—
52W High0.0300 CAD
52W Low0.0300 CAD
Profitability
Gross Margin32.44%
Oper. Margin—
EBITDA Margin—
Profit Margin-8117.81%
ROE-714.55%
ROA-552.88%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.74M $
CapEx (TTM)75.06K $
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.12
Current Ratio—
Quick Ratio—
Book Value/Sh0.0570 CAD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.14.74M
Float—
Insiders—
Institutions—
Technical
SMA 500.0300 (-0.0%)
SMA 2000.0300 (-0.0%)
Beta—
S&P 52W Chg—
Avg Vol (30d)0
Avg Vol (10d)—
Technical Indicators
RSI (14)100.0
MACD0.0000
MACD Signal0.0000
MACD Hist.+0.0000
BB Upper0.0300 CAD
BB Middle0.0300 CAD
BB Lower0.0300 CAD
BB Width0.00%
ATR (14)0.0000 CAD
Vol Ratio (20d)—